Aldeyra CRL on New Drug Application for Treatment of f Dry Eye

 

• Top-Line Data from Dry Eye Chamber Trial and Field Trial Expected in Q2 2025
• Pending Positive Results and Discussions with the FDA, New Drug Application Resubmission Expected Mid-Year 2025

https://www.businesswire.com/news/home/20250403220331/en/Aldeyra-Therapeutics-Receives-Complete-Response-Letter-from-the-U.S.-Food-and-Drug-Administration-for-the-Reproxalap-New-Drug-Application-for-the-Treatment-of-Signs-and-Symptoms-of-Dry-Eye-Disease